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Carcinoma showing thymus-like differentiation
(CASTLE) is a rare malignant neoplasm that was origi-
nally described by Miyauchi et al in 1985 [1]. Since
then, only 25 cases of this unusual tumor have been
reported. This tumor usually arises in the thyroid
gland or soft tissue of the neck [2,3]. Because of the
rarity of CASTLE, definitive management remains
uncertain. Here, we describe a case of CASTLE that had
invaded the anterior mediastinum and was success-
fully and completely resected by left thyroid lobectomy
via a median sternotomy approach. The purposes of
this paper are to present the case, review the pertinent
literature, and to discuss a new approach for CASTLE
that has invaded the anterior mediastinum, because
total resection of these tumors can decrease the local
recurrence rate.
CASE PRESENTATION
A 54-year-old man noted a mass at the left lower
anterior neck 3 months previously. Physical examina-
tion revealed a mass (5 × 4 cm) on the left thyroid. The
mass was firm and movable during swallowing. No
cervical lymph node was palpable and the neck was
not tender to palpation. Chest roentgenogram revealed
that the trachea was displaced to the right. Thyroid
ultrasonography showed a homogeneous and low
echoic mass of 4.8 cm in diameter in the left lobe of the
thyroid. Fine-needle aspiration biopsy (FNAC) was
performed. Cytologic examination indicated papillary
carcinoma and suggested operation. The serum con-
centrations of thyroxine, thyroid-stimulating hormone,
and thyroglobulin were all normal. Computed tomog-
raphy (CT) of the neck showed a soft tissue dense
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Carcinoma showing thymus-like differentiation (CASTLE) is a rare malignant neoplasm that
occurs in the thyroid gland, or head and neck. This tumor arises from either ectopic thymus tissue
or remnants of branchial pouches, which retain the potential to differentiate along the thymus
line. Clinical presentation and imaging can be consistent with a malignant lesion such as thyroid
cancer or thymic carcinoma. Immunohistochemical staining with CD5 can differentiate CASTLE
from other malignant thyroid neoplasms. A 54-year-old male had initially presented with a pain-
less, left neck mass for 3 months. He underwent left thyroid lobectomy via a median sternotomy
approach. Carcinoma showing thymus-like differentiation was the final histopathologic diagnosis.
After 36 months of follow-up, no evidence of recurrence was observed. A median sternotomy is
an excellent approach for CASTLE with anterior mediastinum involvement. Complete resection
is important to improve the long-term survival rate and the locoregional recurrence rate.
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mass, which was located on the inferior left lobe of the
thyroid gland and left upper mediastinum (Figure 1).
The mass displaced and compressed the trachea.
At operation, the tumor was a mass found to
occupy the lower portion of the left thyroid lobe and
extended to the anterior upper mediastinum. Complete
resection of the tumor was successfully achieved by
left thyroid lobectomy via a median sternotomy ap-
proach. Intraoperative findings showed that the well-
capsulated mass taken from the left thyroid gland
was not adherent to the surrounding tissue. The thy-
mus was inspected and palpation revealed a smooth
surface. Therefore, a tumor arising from the thymus
gland was excluded.
Microscopic examination revealed confluent nests
and lobules of epithelioid and spindle-shaped cells
with pleomorphic vesicular nuclei, distinct nucleoli
with small lymphocytes and plasma cell infiltration,
and focal squamous differentiation. Immunohistoche-
mical tests showed that the tumor was positive for
CD5, weakly positive for cytokeratin, and negative
for thyroglobulin and vimentin (Figure 2).
The patient was treated by complete resection and
received no adjunctive radiotherapy. The patient’s
postoperative course was uneventful. The metastatic
follow-up was negative. After 36 months of follow-up,
no evidence of recurrence was observed.
In the literature, a total of 25 cases of CASTLE
have been reported. With our case, this number has
increased to 26 (Table) [1–11]. We examined the meth-
ods of surgery for CASTLE, and the method seems to
be important in prognosis. Six patients were excluded
from further study: for three, the tumors were excised,
two had extrathyroid tumors, and one received 
radiotherapy alone. Of the remaining 19 patients, 
six patients underwent total thyroidectomy, seven
patients underwent subtotal thyroidectomy, and
seven patients underwent total thyroid lobectomy.
The patients who underwent total thyroidectomy
were cases with aggressive tumors and were difficult
to manage. In this group, five showed locoregional
recurrence and only one survived for 2 years without
recurrence. Comparing the groups of subtotal thy-
roidectomy and total thyroid lobectomy, we noted
that those who were treated by subtotal thyroidec-
tomy had higher locoregional recurrence and distant
metastasis rates than those treated by total thyroid
lobectomy. Of the cases who underwent total thyroid
lobectomy, only one case of lung metastasis before
operation was noted. The remaining six cases survived
without locoregional recurrence or distant metasta-
sis. In addition, the patients treated by total thyroid
lobectomy did not receive postoperative radiother-
apy. There were four cases of locoregional recurrence,
one case of distant metastasis and two cases without
recurrence in the subtotal thyroidectomy group. The
outcome of total thyroidectomy and lobectomy of
treatment in CASTLE is uncertain and we need a
larger series of patients to support our data.
DISCUSSION
CASTLE is a rare tumor occurring in the soft tissues
of the neck and thyroid gland. Chan and Rosai mor-
phologically classified tumors derived from ectopic
A B
Figure 1. (A) Non-contrast-enhanced computed tomography shows an isodense mass inside the thyroid gland. (B) The mass displaced
the trachea to the right side and involves the anterior mediastinum.
thymus into four groups: ectopic hamartomatous
thymoma, ectopic cervical thymoma, spindle epithe-
lial tumor with thymus-like differentiation (SETTLE),
and CASTLE [4]. The first two are considered to be
benign and have the same histologic features as thy-
moma. The last two should be considered malignant.
SETTLE occurs in children and young adults, and
often has a late distant recurrence [3].
During fetal development, thymus tissue is de-
rived from the third and fourth branchial pouch, and
descends with growth of the fetus and enters the
mediastinum. These tumors arise from either ectopic
thymus tissue or remnants of branchial pouches,
which retain the potential to differentiate along the
thymus line [1]. It is unknown why ectopic thymus
tissue may develop into these tumor types. According
to previous reports, CASTLE occurs with equal fre-
quency in men and women. Tumors are located on
the left side in approximately two-thirds of cases,
particularly the lower portion of the thyroid gland.
CASTLE often occurs in adults and frequently invades
the adjacent soft tissue and metastasizes to the regional
lymph nodes. These tumors recur in regional nodes
after a long interval and the clinical course is rarely
aggressive [1].
Histologically, CASTLE shows a lobulated and
expansive growth pattern, with fibrous septa di-
viding the tumor, large vesicular nuclei with pro-
minent nucleoli, a low mitotic count, and may be
associated with lymphoplasmacytic infiltration [1,4,5].
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Figure 2. CASTLE of the thyroid gland. (A) The tumor contains numerous fibrous septae giving it a lobulated architecture (hema-
toxylin & eosin; original magnification, 20×). (B) Tumor cells have indistinct borders and large vesicular nuclei with prominent nucle-
oli. A few admixed lymphocytes and plasma cells are also present (hematoxylin & eosin; original magnification, 200×). (C) Some
tumor cells show definite squamous differentiation. Multiple keratinous-resembling Hassall’s corpuscles are present (hematoxylin &
eosin; original magnification, 200×). (D) Immunostaining for CD5 shows tumor cells with cell membrane staining.
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Table. Clinical data for 26 patients with CASTLE
Case Author
Age 
Tumor location Treatment Outcome
(yr)/Sex
1 Miyauchi 51/F Right thyroid lobe Right lobectomy with Alive & NER at 26 yr
et al [1] lower pole cervical LN dissection
2 Miyauchi 59/F Left thyroid lobe Partial lobectomy Local recurrence 17 yr
et al [1] later
3 Miyauchi 47/F Left thyroid lobe with Left lobectomy + modified Alive & NER at 14 yr
et al [1] left RLN invasion RND + left RLN resection
4 Ahuja 67/F Extrathyroid, at carotid & Resection & LN LN metastasis
et al [2] posterior spaces dissection + RT
5 Luo 47/M Extrathyroid, at left Excision + RT Alive & NER at 21 mo
et al [3] parapharyngeal space
6 Willis [4] 25/F Left anterior neck Excision Local recurrence 
after 6 mo
7 Asa [4] 35/M Right thyroid lobe Subtotal thyroidectomy + Subglottic & neck 
right RLN resection recurrence after 9 yr
8 Chan & 69/M Entire thyroid Excision + RT Alive & NER at 2 yr
Rosai [4]
9 Chan & 43/F Left thyroid Excision Local recurrence 
Rosai [4] after 15 yr
10 Mizukami 59/F Right lower thyroid Subtotal thyroidectomy + Alive & NER 2 yr
et al [5] bilateral LN dissection
11 Mizukami 71/M Entire thyroid & extension Total thyroidectomy + Local recurrence & 
et al [5] into lower neck & trachea, RND + laryngotracheal LN metastasis at 6 mo
palpable LN resection
12 Morikawa 38/F Left thyroid Thyroid lobectomy + Alive & NER 3 yr
[6] LN dissection
13 Shek [6] 39/F Right lower thyroid Right lobectomy with Alive & NER 15 mo
isthmus resection
14 Wantanabe 32/F Left thyroid Total thyroidectomy and Local recurrence 5 mo
[6] LN dissection
15 Nassar [6] 39/F Right thyroid Thyroidectomy Recurrence after 6 mo 
in paratracheal LN
16 Tai [6] 34/F Left lower thyroid Left lobectomy Alive & NER 20 yr
17 Kusada 68/M Right thyroid & lung Right lobectomy + Died 11 mo after 
et al [6] metastasis when adjacent operation with 
diagnosed lymphadenectomy lung metastasis
18 Yoneda 54/M Right thyroid Total thyroidectomy + Alive & NER 2 yr
et al [7] resection of segmental 
trachea + right common 
carotid artery + internal 
jugular vein reconstruction
19 Roka 31/M Right thyroid Thyroidectomy + LN recurrence after 
et al [8] functional neck 8 mo; liver metastasis 
dissection after 17 mo; bone 
marrow metastasis 
after 30 mo
20 Roka 31/M Left thyroid Thyroidectomy + bilateral Local recurrence after 
et al [8] modified neck dissection + 19 mo in esophagus & 
lymphadenectomy & subclavian vein
thymectomy
(Contd.)
These tumors are similar to thymic carcinoma of 
lymphoepithelioma-like carcinoma or squamous cell
carcinoma of thyroid, because they are high-grade
malignant neoplasms [1,4].
Immunohistochemical studies can differentiate
CASTLE from other malignant thyroid neoplasms [6].
CASTLEs are immunoreactive for cytokeratin protein,
but not for calcitonin or thyroglobulin. Similar to
thymic carcinoma, CASTLE is immunohistochemically
positive for CD5, but the majority of thymomas or
other malignancies are CD5-negative [12].
On CT scan, the tumor usually shows a well-
defined, soft tissue density, with slight enhancement
after administration of contrast medium. Magnetic res-
onance imaging shows isointensity on T1-weighted
images and hyperintensity on T2-weighted images [7].
FNAC of these tumors may also show spindle cells,
although some reports showed nonspecific findings.
Thus, FNA cytology has limited use for the diagnosis
of CASTLE. Based on the reviewed literature, CASTLE
can be diagnosed by exclusion. Histologic examination
may also provide a definite diagnosis when performed
by an experienced pathologist.
Surgical intervention in these tumors is challeng-
ing and should be reserved for patients with voice or
vocal cord function. There are several possible postop-
erative morbidities, including cord palsy and aspiration
pneumonia, which must be explained to the patient
before operation. Median sternotomy is an excellent
approach, even in cases with mediastinum and pul-
monary involvement [13]. Complete resection of these
tumors is very important to achieve satisfactory long-
term survival. CASTLE with lymph node involvement
has a high risk of recurrence when treated by both
surgery and radiotherapy. Surgery alone is indicated
for patients without lymph node metastasis. The role
of radiotherapy when lymph node metastasis has
occurred can limit subsequent recurrence, but there is
no evidence for benefits from chemotherapy [8].
In summary, CASTLE is a rare malignancy of the
thyroid with fewer than 30 cases reported to date. This
tumor is similar to anaplastic carcinoma or squamous
cell carcinoma and definite diagnosis requires an expe-
rienced pathologist and positive CD5 immunoreac-
tivity. It is important to differentiate this tumor from
anaplastic carcinoma or squamous cell carcinoma,
which have poor prognoses. Surgical excision with or
without radiotherapy is the first choice. CASTLE with
anterior mediastinum involvement is extremely rare.
Surgical management of tumors involving the medi-
astinum is challenging and should be performed by a
median sternotomy approach because of the need for
complete resection of the tumor. Complete resection
is important to improve the long-term survival rate
and locoregional recurrence rate. Therefore, total thy-
roidectomy and total thyroid lobectomy are indicated
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Table. Continued
Case Author
Age 
Tumor location Treatment Outcome
(yr)/Sex
21 Miyauchi 65/F Left lower thyroid & Subtotal thyroidectomy + Alive & NER at 14 yr
et al [9] palpable LN neck dissection + RT
22 Miyauchi 52/M Left lower thyroid & Subtotal thyroidectomy + LN metastasis, tumor
et al [9] palpable LN neck dissection + recurrence in
tracheoplasty + RT mediastinum at 6 yr
23 Miyauchi 29/F Right middle-lower Subtotal thyroidectomy + LN metastasis, tumor 
et al [9] thyroid & palpable LN neck dissection + recurrence in lung at 
tracheoplasty + RT 3 yr
24 Kakudo 59/M Left thyroid lobe with Subtotal thyroidectomy + Pulmonary metastasis 
et al [10] LN palpable modified RND + RT at 14 mo
25 Damiani 47/F Central portion of Tracheostomy + RT Unaltered for 7 yr, 
et al [11] thyroid & extending died of myocardial 
to tracheal wall infarction
26 Chan et al 54/M Left thyroid Median sternotomy + Alive & NER 36 mo
[this case] left thyroid lobectomy
LN = lymph node; NER = no evident recurrence; RLN = recurrent laryngeal nerve; RND = radical neck dissection; RT = radiotherapy.
when the tumor involves the bilateral or unilateral
thyroid gland without nodal status. Subtotal thyroid-
ectomy has never been performed for this cancer.
However, a longer follow-up in a larger series of
patients is needed to support our result.
REFERENCES
1. Miyauchi A, Kuma K, Matsuzuka F, et al. Intrathy-
roidal epithelial thymoma: an entity distinct from
squamous cell carcinoma of the thyroid. World J Surg
1985;9:128–35.
2. Ahuja AT, Chan ES, Allen PW, et al. Carcinoma show-
ing thymic-like differentiation (CASTLE tumor). AJNR
Am J Neuroradiol 1998;19:1225–8.
3. Luo CM, Hsueh C, Chen TM. Extrathyroid carcinoma
showing thymus-like differentiation (CASTLE) tumor—
a new case report and review of literature. Head Neck
2005;27:927–33.
4. Chan JK, Rosai J. Tumors of the neck showing thymic
or related branchial pouch differentiation: a unifying
concept. Hum Pathol 1991;22:349–67.
5. Mizukami Y, Kurumaya H, Yamada T, et al. Thymic
carcinoma involving the thyroid gland: report of two
cases. Hum Pathol 1995;26:576–9.
6. Kusada N, Hara Y, Kobayashi S, et al. A case of aggres-
sive carcinoma showing thymus-like differentiation
with distant metastases. Thyroid 2005;15:1383–8.
7. Yoneda K, Matsui O, Kobayashi T, et al. CT and MRI
findings of carcinoma showing thymus-like differenti-
ation. Radiat Med 2005;23:451–5.
8. Roka S, Kornek G, Schuller J, et al. Carcinoma showing
thymic-like elements—a rare malignancy of the thyroid
gland. Br J Surg 2004;91:142–5.
9. Miyauchi A, Ishikawa H, Maeda M. Intrathyroidal
epithelial thymoma: a report of 6 cases with immuno-
histochemical and ultrastructural studies. Endocr Surg
1989;6:289–95.
10. Kakudo K, Mori I, Tamaoki N, et al. Carcinoma of pos-
sible thymic origin presenting as a thyroid mass: a new
subgroup of squamous cell carcinoma of the thyroid. 
J Surg Oncol 1988;38:187–92.
11. Damiani S, Filotico M, Eusebi V. Carcinoma of the thy-
roid showing thymoma-like features. Virchows Arch A
Pathol Anat Histopathol 1991;418:463–6.
12. Dorfman DM, Shahsafaei A, Miyauchi A. Intrathyroidal
epithelial thymoma (ITET)/carcinoma showing thymus-
like differentiation (CASTLE) exhibits CD5 immunore-
activity: new evidence for thymic differentiation.
Histopathology 1998;32:104–9.
13. Bacha EA, Chapelier AR, Macchiarini P, et al. Surgery
for invasive primary mediastinal tumors. Ann Thorac
Surg 1998;66:234–9.
Kaohsiung J Med Sci November 2008 • Vol 24 • No 11596
L.P. Chan, F.Y. Chiang, K.W. Lee, and W.R. Kuo
Kaohsiung J Med Sci November 2008 • Vol 24 • No 11 597
收文日期：97 年 5 月 2 日
接受刊載：97 年 7 月 31 日
通訊作者：江豐裕醫師
高雄醫學大學附設醫院耳鼻喉科
高雄市三民區自由一路 100號
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CASTLE 為好發於頭頸部及甲狀腺的罕見惡性腫瘤，其發生原因可能是來自異位胸腺
組織或胚胎時期胸腺下降遺留的組織產生癌化所引起。臨床表現及影像並不能和源自
甲狀腺或胸腺腫瘤區分，但 CD 5 免疫組織染色呈現陽性反應，可與甲狀腺其他腫瘤
區分。一位 54 歲男性病患，主訴頸部有一無壓痛感之腫瘤已三個月，病人經胸骨切
開術，進行左全葉甲狀腺切除術，將腫瘤完整切除。病理組織切片，診斷為 
carcinoma showing thymus-like differentiation (CASTLE)。病人術後恢復良
好，持續門診追蹤 36 個月後並無復發跡象。當 CASTLE 侵犯前中隔腔時，使用正中
胸骨切開術可以有效將腫瘤完全切除。
關鍵詞：CASTLE，胸骨切開術，胸腺，甲狀腺
(高雄醫誌 2008;24:591–7)
